Evidence map›Paper›PMID 31822778›Full record

ArticleLeukemia2020

Correction: Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemia.

S Modvig, H O Madsen, S M Siitonen, S Rosthøj, A Tierens, V Juvonen, L T N Osnes, H Vålerhaugen, M Hultdin, I Thörn and 14 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Leukemia, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

S ModvigDepartment of Clinical Immunology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
H O MadsenDepartment of Clinical Immunology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
S M SiitonenHelsinki University Ctrl. Hospital, Helsinki, Finland.
S RosthøjSection of Biostatistics, University of Copenhagen, Copenhagen, Denmark.
A TierensLaboratory Medicine Program, University Health Network and University of Toronto, Toronto, ON, Canada.
V JuvonenDepartment of Clinical Chemistry and Laboratory Division, University of Turku and Turku University Hospital, Turku, Finland.
L T N OsnesDepartment of Immunology, Oslo University Hospital Rikshospitalet, Oslo, Norway.
H VålerhaugenDepartment of Pathology, Laboratory of Molecular Pathology, Oslo University Hospital, Oslo, Norway.
M HultdinDepartment of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden.
I ThörnDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
R MatuzevicieneDepartment of Physiology, Biochemistry, Microbiology and Laboratory Medicine, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
M StoskusHematology, Oncology and Transfusion Medicine Centre, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.
M MarincevicDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
L FogelstrandDepartment of Clinical Chemistry, Sahlgrenska University Hospital, and Department of Clinical Chemistry and Transfusion Medicine, Institute of Biomedicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
A LilleorgDepartment of Clinical Immunology, North Estonia Medical Centre, Tallinn, Estonia.
N ToftDepartment of Hematology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
O G JónssonChildren's Hospital, Landspitali University Hospital, Reykjavik, Iceland.
K PruunsildTallinn Children's Hospital, Tallinn, Estonia.
G VaitkevicieneChildren's Hospital, Affiliate of Vilnius University Hospital Santariskiu Klinikos, Vilnius, Lithuania.
K VettenrantaDepartment of Pediatrics, Helsinki University Children's Hospital and University of Helsinki, Helsinki, Finland.
B LundDepartment of Pediatrics, St. Olavs University Hospital and Department of Clinical and Molecular Medicine, NTNU, Trondheim, Norway.
J AbrahamssonInstitution of Clinical Sciences, Department of Pediatrics, Sahlgrenska University Hospital, Gothenburg, Sweden.
K SchmiegelowDepartment of Pediatrics and Adolescent Medicine, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
H V MarquartDepartment of Clinical Immunology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark. hanne.marquart@regionh.dk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiers

PMID31822778

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.